In combination, the tumor-promoting pro-inflammatory activity as well as the immunosuppressive activity may represent crucial molecular processes underlying the potent oncogenicity of combined HH/GLI and IL6/STAT3 signaling. This evidence concerns the gene IL6 and neoplasm.